Stay updated with breaking news from Pediatric Brain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Plus now has $23 million in active awards support for the Company's targeted radiotherapeutic pipeline Funding for pediatric brain cancer treatment is expected to begin in Q3 2024, pending contract finalization
A recent phase 2 trial revealed that the combination of Tafinlar and Mekinist benefitted children with BRAF-mutated low-grade gliomas.
/PRNewswire/ -- The "Novel Drug Delivery Systems (NDDS) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global...
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Novel Drug Delivery Systems (NDDS) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Novel Drug Delivery Systems (NDDS) Market to Reach $61 Billion by 2030The global market for Novel Drug Delivery Systems (NDDS) estimated at US$12.7 Billion in the year 2022, is projected to reach a revised size of US$61 Billion by 2030, growing at a CAGR of 21.6% over the analysis period 2022-2030. Nanoparticles, o
/PRNewswire/ -- The "Novel Drug Delivery Systems (NDDS): Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global...